119 related articles for article (PubMed ID: 10192657)
1. Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis.
Sandbaek G; Bjørnsen S; Brosstad F
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):87-91. PubMed ID: 10192657
[TBL] [Abstract][Full Text] [Related]
2. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
5. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
[TBL] [Abstract][Full Text] [Related]
8. Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex.
Hafner G; Schinzel H; Ehrenthal W; Wagner C; Konheiser U; Zotz R; Lotz J; Blank R; Weilemann LS; Prellwitz W
Ann Hematol; 1993 Sep; 67(3):121-5. PubMed ID: 8373897
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
10. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
Solymoss S; Bovill EG
Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609
[TBL] [Abstract][Full Text] [Related]
11. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C
Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109
[TBL] [Abstract][Full Text] [Related]
12. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of F1 + 2/TAT ratios in Japanese patients with antiphospholipid syndrome].
Naitoh S; Ieko M; Takeda M; Atsumi T; Koike T
Rinsho Byori; 2000 Jun; 48(6):540-6. PubMed ID: 10897673
[TBL] [Abstract][Full Text] [Related]
14. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
Halbmayer WM; Haushofer A; Toth E
Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
[TBL] [Abstract][Full Text] [Related]
15. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
[TBL] [Abstract][Full Text] [Related]
16. Variation in hemostatic parameters after intra-arterial and intravenous administration of iodinated contrast media.
Manotti C; Quintavalla R; Ugolotti U; Del Favero C; Dettori AG
Invest Radiol; 1992 Dec; 27(12):1025-30. PubMed ID: 1473919
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD
J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503
[TBL] [Abstract][Full Text] [Related]
18. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
Gulba DC; Barthels M; Westhoff-Bleck M; Jost S; Rafflenbeul W; Daniel WG; Hecker H; Lichtlen PR
Circulation; 1991 Mar; 83(3):937-44. PubMed ID: 1900225
[TBL] [Abstract][Full Text] [Related]
19. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
20. Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.
Knudsen L; Hasenkam JM; Kure HH; Hughes P; Bellaiche L; Ahlburg P; Djurhuus C
Thromb Res; 1996 Oct; 84(1):45-54. PubMed ID: 8885146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
